Advertisement

AIDS and Behavior

, Volume 8, Issue 3, pp 345–355 | Cite as

Changes in Neuropsychological Functioning with Progression of HIV-1 Infection: Results of an 8-Year Longitudinal Investigation

  • Teri T. Baldewicz
  • Jane Leserman
  • Jane Leserman
  • Susan G. Silva
  • John M. Petitto
  • Robert N. Golden
  • Diana O. Perkins
  • Julie Barroso
  • Dwight L. Evans
Article

Abstract

Despite the advent of more effective treatments for HIV-1 infection, cognitive impairment is still frequent and questions remain regarding which areas of impairment are more common in the different disease stages. This study investigated cognitive performance over an 8-year period of time in 59 HIV-1 seropositive (HIV-1+) men who were clinically asymptomatic at study entry, in comparison to a cohort of 55 HIV-1 seronegative (HIV-1) men. Every 6 months we examined cognitive functioning in 5 domains—fine motor speed, attention, verbal memory, executive functioning, and speed of information processing. We found that patients with AIDS scored significantly worse on fine motor speed and speed of information processing than HIV-1 individuals and the HIV-1+ non-AIDS patients. In addition, the HIV-1+ non-AIDS patients performed more poorly than the HIV-1 group on speed of information processing. Depressive symptoms were also associated with diminished performance on measures of attention, executive functioning, and speed of information processing. Further research is needed to examine the effects of disease stage and depression on cognitive impairment in the era of new HIV treatments.

HIV-1 infection cognitive function fine motor speed speed of information processing depression 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. Albert, S. M., Marder, K., Dooneief, G., Bell, K., Sano, M., Todak, G., and Stern, Y. (1995). Neuropsychologic impairment in early HIV infection. Arisk factor for work disability. Archives of Neurology, 52, 525–530.Google Scholar
  2. Army Individual Test Battery. (1944). Manual of directions and scoring. Washington, DC: War Department, Adjutant General's Office.Google Scholar
  3. Aylward, E. H., Henderer, J. D., McArthur, J. C., Brettschneider, P. D., Harris, G. J., Barta, P. E., and Pearlson, G. D. (1993). Reduced basal ganglia volume in HIV-1-associated dementia: Results from quantitative neuroimaging. Neurology, 43, 2099–2104.Google Scholar
  4. Basso, M. R., and Bornstein, R. A. (2000). Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months. Journal of Clinical and Experimental Neuropsychology, 22, 208–218.Google Scholar
  5. Berger, J. R., Nath, A., Greenberg, R. N., Andersen, A. H., Greene, R. A., Bognar, A., and Avison, M. J. (2000). Cerebrovascular changes in the basal ganglia with HIV dementia. Neurology, 54, 921–926.Google Scholar
  6. Bornstein, R. A., Nasrallan, H. A., Para, M. F., Whitare, C. C., Rosenberger, P., and Fass, R. J. (1993). Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS, 7, 519–524.Google Scholar
  7. Bornstein, R. A., Nasrallah, H. A., Para, M. F., Whitacre, C. C., Rosenberger, P., Fass, R. J., and Rice, R., Jr. (1992). Neuropsychological performance in asymptomatic HIV infection. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 386–394.Google Scholar
  8. Castellon, S. A., Hinkin, C. H., and Myers, H. F. (2000). Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection. Journal of the International Neuropsychological Society, 6, 336–347.Google Scholar
  9. Centers for Disease Control and Prevention. (1992). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbidity and Mortality Weekly Report, 41(No. RR-17), 1–19.Google Scholar
  10. Cohen, R. A., Boland, R., Paul, R., Tashima, K. T., Schoenbaum, E. E., Celentano, D. D., Schuman, P., Smith, D. K., and Carpenter, C. C. J. (2001). Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS, 15, 341–345.Google Scholar
  11. Damos, D. L., John, R. S., Parker, E. S., and Levine, A. M. (1997). Cognitive function in asymptomatic HIV infection. Archives of Neurology, 54, 179–185.Google Scholar
  12. Delis, D. C., Kramer, J. H., Kaplan, E., and Ober, B. A. (1987). California Verbal Learning Test, Form II (Research ed.). San Antonio, TX: The Psychological Corporation.Google Scholar
  13. Delis, D.C., McKee, R., Massman, P.J.,et al (1991). Alternate form of the California Verbal Learning Test: Development and reliability. The Clinical Neuropsyhologist, 5, 154–162.Google Scholar
  14. Delis, D. C., Peavy, G., Heaton, R., Butters, N., Salmon, D. P., Taylor, M., Stout, J., Mehta, P., Ryan, L., White, D., Atkinson, J. H., Chandler, J. L., McCutchan, J. A., Grant, I., and the HNRC Group. (1995). Do patients with HIV-associated minor cognitive/motor disorder exhibit a “subcortical” memory profile? Evidence using the California Verbal Learning Test. Assessment, 2(2), 151–165.Google Scholar
  15. Ellis, R. J., Deutsch, R., Heaton, R. K., Marcotte, T. D., McCutchan, J. A., Nelson, J. A., Abramson, I., Thal, L. J., Atkinson, J. H., Wallace, M. R., and Grant, I. (1997). Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Archives of Neurology, 54, 416–424.Google Scholar
  16. Evans, D. L., Bauer, R., Leserman, J., Mason, K. I., and Petitto, J. (2002). Neuropsychiatric manifestations of HIV-1 infection and AIDS. In D. Charney, J. Coyle, K. Davis, and C. Nemeroff (Eds.), Psychopharmacology: The fifth generation of progress (pp.1281–1299). New York: Raven press.Google Scholar
  17. Ferrando, S. J., Rabkin, J. G., Van Gorp, W., Lin, S. H., and McElhiney, M. (2003). Londitudinal improvement in psychomotor processing speed is associated with potent combination antiretroviral therapy in HIV-1 infection. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 208–214.Google Scholar
  18. Ferrando, S., van Gorp, W., McElhiney, M., Goggin, K., Sewell, M., and Rabkin, J. (1998). Highly active antiretroviral treat-ment in HIV infection: Benefits for neuropsychological function. AIDS, 12, F65-F70.Google Scholar
  19. Gill, D. M., Reddon, J. R., Stefanyk, W. O., and Hans, H. S. (1986). Finger tapping: Effects of trials and sessions. Perception and Motor Skills, 62, 675–678.Google Scholar
  20. Goggin, K. J., Zisook, S., Heaton, R. K., Atkinson, J. H., Marshall, S., McCutchan, J. A., Chandler, J. L., and Grant, I. (1997). Neuropsychological performance of HIV-1 infected men with major depression. HNRC Group. HIV Neurobehavioral Research Center. Journal of the International Neuropsychological Society, 3, 457–464.Google Scholar
  21. Golden, C. J. (1978). Stroop Color and Word Test. Chicago, IL: Stoelting.Google Scholar
  22. Goldstein, G., and Watson, J. R. (1989). test–retest reliability of the Halstead-Reitan battery and the WAIS in a neuropsychiatric population. Clinical Neuropsychologist, 3, 265–273.Google Scholar
  23. Goodkin, K., Wilkie, F. L., Concha, M., Symes, S., Baldewicz, T. T., Asthana, D., Fujimura, R. K., Lee, D., van Zuilen, M. H., Khamis, I., and Shapshak, P. (2001). Aging and neuro-AIDS conditions: Interaction with the changing spectrum of HIV-1 associated morbidity and mortality post-HAART? Journal of Clinical Epidemiology, 54(Suppl. 1), S35-S43.Google Scholar
  24. Grassi, B., Garghentini, G., Campana, A., Grassi, E., Bertelli, S., Cinque, P., Epifani, M., Lazzarin, A., and Scarone, S. (1999). Spatial working memory in asymptomatic HIV-infected subjects. Journal of Neuropsychiatry and Clinical Neurosciences, 11, 387–391.Google Scholar
  25. Halstead, W. C. (1947). Brain and intelligence. Chicago: University of Chicago Press.Google Scholar
  26. Hamilton, M. (1960). A rating scale for depression. Journal of Neurological and Neurosurgical Psychiatry, 23, 56–61.Google Scholar
  27. Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., McCutchan, J. A., Taylor, M. J., Kelly, M. D., Ellis, R. J., et al. (1995). The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. Journal of the International Neuropsychological Society, 1, 231–251.Google Scholar
  28. Heaton, R. K., Velin, R. A., McCutchan, J. A., Gulevich, S. J., Atkinson, J. H., Wallace, M. R., Godfrey, H. P., Kirson, D. A., and Grant, I. (1994). Neuropsychological impairment in human immunodeficiency virus-infection: Implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosomatic Medicine, 56, 8–17.Google Scholar
  29. Ickovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P., Boland, R. J., Moore, J., and HIV Epidemiology Research Study Group. (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. JAMA, 285, 1466–1474.Google Scholar
  30. Kaufman, A. S., McLean, J. E., and Kaufman, J. C. (1995). The fluid and crystallized abilities of white, black, and his-panic adolescents and adults, both with and without an education covariate. Journal of Clinical Psychology, 51, 636–647.Google Scholar
  31. La Rue, A., Romero, L. J., Ortiz, I. E., Liang, H. C., and Lindeman, R. D. (1999). Neuropsychological performance of Hispanic and non-Hispanic older adults: An epidemiologic survey. Clinical Neuropsychology, 13, 474–486.Google Scholar
  32. Leserman, J., Jackson, E. D., Petitto, J. M., Golden, R. N., Silva, S. G., Perkins, D. O., Cai, J., Folds, J. D., and Evans, D. L. (1999). Progression to AIDS: The effects of stress, depressive symptoms, and social support. Psychosomatic Medicine, 61, 397–406.Google Scholar
  33. Leserman, J., Petitto, J. M., Golden, R. N., Gaynes, B. N., Gu, H., Perkins, D. O., Silva, S. G., Folds, J. D., and Evans, D. L. (2000). The impact of stressful life events, depression, social support, coping and cortisol on progression to AIDS. American Journal of Psychiatry, 157, 1221–1228.Google Scholar
  34. Leserman, J., Petitto, J.M., Gu, H., Gaynes, B.N., Barroso, J., Golden, R. N., Perkins, D. O., Folds, J. D., and Evans, D. L. (2002). Progression to AIDS, a clinical AIDS condition, and mortality: Psychosocial and physiological predictors. Psychological Medicine, 32, 1059–1073.Google Scholar
  35. Leserman, J., Petitto, J.M., Perkins, D.O., Folds, J.D., Golden, R. N., and Evans, D. L. (1997). Severe stress, depressive symptoms, and change in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study. Archives of General Psychiatry, 54, 279–285.Google Scholar
  36. Mayeux, R., Stern, Y., Tang, M. X., Todak, G., Marder, K., Sano, M., Richards, M., Stein, Z., Ehrhardt, A. A., and Gorman, J. M. (1993). Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology, 43, 176–182.Google Scholar
  37. Miller, E. N., Selnes, O. A., McArthur, J. C., Satz, P., Becker, J. T., Cohen, B. A., Sheridan, K., Machado, A. M., van Gorp, W. G., and Visscher, B. (1990). Neuropsychological performance in HIV-1 infected homosexual men: The multicenter AIDS cohort study. Neurology, 40, 197–203.Google Scholar
  38. Osowiecki, D. M., Cohen, R. A., Morrow, K. M., Paul, R. H., Carpenter, C. C., Flanigan, T., and Boland, R. J. (2000). Neurocognitive and psychological contributions to quality of life in HIV-1-infected women. AIDS, 14, 1327–1332.Google Scholar
  39. Page-Shafer, K., Delorenze, G. N., Satariano, W. A., and Winkelstein, W., Jr. (1996). Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. Annals of Epidemiology, 6, 420–430.Google Scholar
  40. Peavy, G., Jacobs, D., Salmon, D. P., Butters, N., Delis, D. C., Taylor, M., Massman, P., Stout, J. C., Heindel, W. C., Kirson, D., et al. (1994). Verbal memory performance of patients with human immunodeficiency virus infection: Evidence of subcortical dysfunction. The HNRC Group. Journal of Clinical and Experimental Neuropsychology, 16(4), 508–523.Google Scholar
  41. Reger, M., Welsh, R., Razani, J., Martin, D. J., and Boone, K. B. (2002). Ameta-analysis of the neuropsychological sequelae of HIV infection. Journal of the International Neuropsychological Society, 8, 410–424.Google Scholar
  42. Ruff, R. M., Evans, R. W., and Light, R. H. (1986). Automatic detection and controlled search: A paper and pencil approach. Perceptual and Motor Skills, 62, 407–416.Google Scholar
  43. Ruff, R. M., Niemann, H., Allen, C. C., et al. (1992). The Ruff 2 and 7 selective attention test: A neuropsychological application. Perceptual and Motor Skills, 75, 1311–1319.Google Scholar
  44. Sacktor, N. C., Bacellar, H., Hoover, D. R., Nance-Sproson, T. E., Selnes, O. A., Miller, E. N., Dal Pan, G. J., Kleeberger, C., Brown, A., Saah, A., and McArthur, J. C. (1996). Psychomotor slowing in HIV infection: A predictor of dementia, AIDS, and death. Journal of Neurovirology, 2, 404–410.Google Scholar
  45. Sacktor, N. C., Skolasky, R. L., Lyles, R. H., Esposito, D., Selnes, O. A., and McArthur, J. C. (2000). Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. Journal of Neurovirology, 6, 84–88.Google Scholar
  46. Sahakian, B. J., Elliott, R., Low, N., Mehta, M., Clark, R. T., and Pozniak, A. L. (1995). Neuropsychological deficits in tests of executive function in asymptomatic and symptomatic HIV-1 seropositive men. Psychological Medicine, 25, 1233–1246.Google Scholar
  47. SAS Institute. (1999). SAS/STAT user's guide (Version 7). Cary, NC: SAS Institute.Google Scholar
  48. Selnes, O. A., Galai, N., Bacellar, H., Miller, E. N., Becker, J. T., Wesch, J., Van Gorp, W., and McArthur, J. C. (1995). Cognitive performance after progression to AIDS: A longitudinal study from the Multicenter AIDS Cohort Study. Neurology, 45, 267–275.Google Scholar
  49. Shipley, W. C. (1967). Shipley Institute of Living Scale (SILS).Los Angeles: Western Psychological Services.Google Scholar
  50. Spitzer, R. L., Williams, J. B. W., Gibbon, M., and First, M. B. (1990). Structured Clinical Interview for DSM-III-R: Non-patient edition (SCID-NP, Version 1.0). Washington, DC: American Psychiatric Press.Google Scholar
  51. Spreen, O., and Strauss, E. (1991). A compendium of neuropsychological tests. New York: Oxford University Press.Google Scholar
  52. Stern, Y., McDermott, M. P., Albert, S., Palumbo, D., Selnes, O. A., McArthur, J., Sacktor, N., Schifitto, G., Kieburtz, K., Epstein, L., Marder, K. S., and Dana Consortium on the Therapy of HIV-Dementia and Related Cognitive Disorders. (2001). Factors associated with incident human immunodeficiency virus dementia. Archives of Neurology, 58, 473–479.Google Scholar
  53. Stout, J. C., Ellis, R. J., Jernigan, T. L., Archibald, S. L., Abramson, I., Wolfson, T., McCutchan, J. A., Wallace, M. R., Atkinson, J. H., and Grant, I. (1998). Progressive cerebral volume loss in human immunodeficiency virus infection: A longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Archives of Neurology, 55(2), 161–168.Google Scholar
  54. Suarez, S., Baril, L., Stankoff, B., Khellaf, M., Dubois, B., Lubetzki, C., Bricaire, F., and Haum, J. J. (2001). Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy. AIDS, 15, 195–200.Google Scholar
  55. Tozzi, V., Balestra, P., Galgani, S., Narciso, P., Ferri, F., Sebastiani, G., D'Amato, C., Affricano, C., Pigorini, F., Pau, F. M., De Felici, A., and Benedetto, A. (1999). Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS, 13, 1889–1897.Google Scholar
  56. Villa, G., Solida, A., Moro, E., Tavolozza, M., Antinori, A., De Luca, A., Murri, R., and Tamburrini, E. (1996). Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study. European Neurology, 36, 125–133.Google Scholar
  57. Wechsler, D. (1981). Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation.Google Scholar
  58. White, D. A., Heaton, R. K., and Monsch, A. U. (1995). Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center. Journal of the Inter-national Neuropsychological Society, 1, 304–315.Google Scholar
  59. Wiley, C. A., Soontornniyomkij, V., Radhakrishnan, L., Masliah, E., Mellors, J., Hermann, S. A., Dailey, P., and Achim, C. L. (1998). Distribution of brain HIV load in AIDS. Brain Pathology, 8, 277–284.Google Scholar
  60. Wilkie, F. L., Goodkin, K., Eisdorfer, C., Feaster, D., Morgan, R., Fletcher, M. A., Blaney, N., Baum, M., and Szapocznik, J. (1998). Mild cognitive impairment and risk of mortality in HIV-1 infection. Journal of Neuropsychiatry and Clinical Neurosciences, 10, 125–132.Google Scholar
  61. York, M. K., Franks, J. J., Henry, R. R., and Hamilton, W. J. (2001). Verbal working memory storage and processing deficits in HIV-1 asymptomatic and symptomatic individuals. Psychological Medicine, 31(7), 1279–1291.Google Scholar

Copyright information

© Springer Science+Business Media, Inc. 2004

Authors and Affiliations

  • Teri T. Baldewicz
    • 1
  • Jane Leserman
    • 2
  • Jane Leserman
    • 3
  • Susan G. Silva
    • 4
  • John M. Petitto
    • 5
  • Robert N. Golden
    • 2
  • Diana O. Perkins
    • 2
  • Julie Barroso
    • 6
  • Dwight L. Evans
    • 7
  1. 1.Department of Clinical OperationsInveresk, CaryNorth Carolina
  2. 2.Department of PsychiatryUniversity of North Carolina School of MedicineChapel HillNorth Carolina
  3. 3.Department of MedicineUniversity of North Carolina School of MedicineChapel HillNorth Carolina
  4. 4.Departments of Psychiatry and Behavioral Sciences and Duke Clinical Research InstituteDuke University Medical CenterDurhamNorth Carolina
  5. 5.Departments of Psychiatry, Neuroscience, and PharmacologyUniversity of FloridaGainesvilleFlorida
  6. 6.School of NursingUniversity of North CarolinaChapel HillNorth Carolina
  7. 7.Departments of Psychiatry, Medicine, and NeuroscienceUniversity of Pennsylvania School of MedicinePhiladelphiaPennsylvania

Personalised recommendations